Navigation Links
MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results
Date:11/14/2007

d, (8) receive required regulatory approvals, (9) successfully conduct clinical trials in a timely manner, (10) establish its competitive position for its products, (11) develop and commercialize products that are superior to existing or newly developed competitor products, (12) develop products without any defects, (13) have sufficient capital resources to fund its operations, (14) protect its intellectual property rights and patents, (15) implement its sales and marketing strategy, (16) successfully attract and retain collaborative partners, (17) successfully commercialize and gain market acceptance for its Keflex products, (18) successfully obtain sufficient manufactured quantities of its drug products at acceptable rates, and (19) retain its senior management and other personnel. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. MiddleBrook undertakes no obligation to update or revise the information in this announcement, whether as a result of new information, future events or circumstances or otherwise.

MIDDLEBROOK PHARMACEUTICALS, INC.

CONDENSED STATEMENTS OF OPERATIONS

(Unaudited)

Three Months Ended Sept 30, Nine Months Ended Sept 30,

2007 2006 2007 2006

Product sales $3,144,532 $2,369,975 $7,598,127 $3,566,563

Costs and

expenses:

Cost of product

sales 1,183,772 440,159 1,864,643 517,765

Research and

development 5,509,093 5,737,047 18,485,164 19,700,263

Selling, general

and administrative 6,475,742 6,069,529 20,473,947 13,001,312

Total

expenses 13,168,607 12,246,735 40,823,754 33,219,340

Loss from

opera
'/>"/>

SOURCE MiddleBrook Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. MiddleBrook Pharmaceuticals Raises Up to $10 Million from Deerfield Management
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
7. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
8. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
9. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
10. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
11. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 04, 2015 Theme and plugin developers from ... pack for Final Cut Pro X entitled ProFont NoteBook , ... to any FCPX editors project.” Said Christiana Austin, CEO of ... to add animated font to their FCPX media.” , With ... all within Final Cut Pro X. ProFont Notebook offers users ...
(Date:3/4/2015)... CA (PRWEB) March 04, 2015 Bird ... commercial, industrial and residential applications now offers its popular ... , The humane, highly efficient bird deterrent ... to match the color and décor of the building ... standard colors—brick red, white, crystal clear, light grey, brown, ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 Professionals with ... more targeted outreach from companies, according to a new ... 2014 survey of 235 professionals with disabilities , ... online job search tools, including ones that are geared ... work. Some highlights:, ,     Online job search ...
(Date:3/4/2015)... March 04, 2015 Rocket Builders’ “Ready ... Columbian companies that have the best prospect for growth ... when we choose the Ready to Rocket companies, we ... technical innovation with market opportunity. Prizm Media Inc. is ... right customers at the right time,” said Reg Nordman, ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 The medical ... companies whose management forgot – or ignored or didn't ... Validate the market based on physician input before proceeding ... – more specifically, founders – become so enamored of ... key question: Will physicians use the device?” says ...
Breaking Medicine News(10 mins):Health News:Announcing a New Title Pack from Pixel Film Studios, ProFont NoteBook for Final Cut Pro X 2Health News:Plastic Bird Spikes Now Come in 7 Colors to Blend in With Their Surroundings 2Health News:Job Seekers with Disabilities Seek Targeted Outreach from Employers and Online Job Search Tools, says New Think Beyond The Label Survey 2Health News:Job Seekers with Disabilities Seek Targeted Outreach from Employers and Online Job Search Tools, says New Think Beyond The Label Survey 3Health News:Healthcare Lead Generation Leader Prizm Media Inc. is “Ready to Rocket” 2Health News:Healthcare Lead Generation Leader Prizm Media Inc. is “Ready to Rocket” 3Health News:Want to Succeed in Medical Technology? Don't Innovate in a Vacuum 2Health News:Want to Succeed in Medical Technology? Don't Innovate in a Vacuum 3
... NEW BRUNSWICK, N.J., May 13 Johnson & Johnson ... Deutsche Bank 34th Annual Health Care Conference on Tuesday, ... Sheri McCoy, Worldwide Chairman, Pharmaceuticals Group for Johnson ... scheduled at 10:50 a.m. (Eastern Time).This broadcast will be ...
... 13 Accumetrics, Inc. announces that it has enrolled ... ( G auging R esponsiveness with A ... hrombosis A nd S afety). The trial ... clinicians with actionable information for patients who are poor ...
... Shengtai,Pharmaceutical, Inc. (OTC Bulletin Board: SGTI) ("Shengtai" or ... pharmaceutical grade,glucose products in China, today announced that ... ended March 31, 2009 after the close of ... Management will conduct a conference call,on Friday, May ...
... (Nasdaq: ESRX ) announced that it will present ... May 19, 2009 at 10:10 a.m. EDT at the InterContinental ... the Internet and can be accessed on the investor relations ... RealPlayer or Windows Media Player is needed to listen ...
... Winner Medical Group Inc.,(OTC Bulletin Board: WMDG) ("Winner Medical", or ... ended March 31,2009. The Company,s results are detailed in its ... Commission. , , Second Quarter 2009 Highlights, ... 15.31% over the second quarter of, ...
... expression and activity of Cystathionase is reduced in ... and impaired generation of hydrogen sulphide, two factors ... resistance. , In the present study the analysis ... presence of an inverted repeat sequence. Administration of ...
Cached Medicine News:Health News:Accumetrics, Inc. Announces 1000th Patient Enrolled in GRAVITAS Trial 2Health News:Shengtai Pharmaceutical Schedules 2009 Third Quarter Financial Results and Conference Call 2Health News:Shengtai Pharmaceutical Schedules 2009 Third Quarter Financial Results and Conference Call 3Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 2Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 3Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 4Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 5Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 6Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 7Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 8Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 9Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 10Health News:Winner Medical Reports Second Quarter Fiscal 2009 Results 11Health News:Farnesoid X receptor regulates cystathionase 2
(Date:3/3/2015)... AUSTIN, Texas , March 3, 2015  UnaliWear ... that provides advanced support for seniors that guards against ... The new wearable – the Kanega ... of its kind to use an easy speech interface ... update medical information without human input. ...
(Date:3/3/2015)... 3, 2015  Columbia Laboratories, Inc. (Nasdaq: ... Company"), a specialty pharmaceutical company focused on pharmaceuticals for ... the 27th Annual ROTH Conference, which will take place ... Dana Point, California . Management,s presentation ... a.m. Pacific Time (12:00 p.m. Eastern Time) in the ...
(Date:3/3/2015)... BARCELONA, Spain , March 3, 2015  AT&T ... AEX: PHIA) today announced that  AT&T  is the connectivity ... service. GoSafe was designed to help provide peace of ... giving them the freedom to live active lives with ... when they need it. The AT&T network 2 ...
Breaking Medicine Technology:UnaliWear's Wearable For Seniors Extends Independence With Advanced Technology 2AT&T Providing Connectivity for Philips GoSafe Mobile Medical Alert System, Empowering United States Seniors to be Connected to Emergency Care On-the-Go 2AT&T Providing Connectivity for Philips GoSafe Mobile Medical Alert System, Empowering United States Seniors to be Connected to Emergency Care On-the-Go 3AT&T Providing Connectivity for Philips GoSafe Mobile Medical Alert System, Empowering United States Seniors to be Connected to Emergency Care On-the-Go 4
One inch disposable patch electrode uses a specially formulated adhesive solid gel. Reusable lead wire with snap connector provides economic benefits. Ideal for sleep studies where leg movement or EK...
10-mm (0.4-in) diameter cups have multi-color lead wires and 2-mm (0.08-in) holes for easy paste/collodion application. Available in a variety of lengths to suit many different needs....
... head cap systems are packaged to provide ... Electro-Cap System features pure tin electrodes positioned ... you place your order, please specify which ... cap system and whether you want regular ...
... Made with elastic fabric, these head ... you need to begin testing. Each Electro-Cap ... to the International 10-20 System. When you ... you are using with your head cap ...
Medicine Products: